Does the N-terminally truncated sphingosine-1-phosphate receptor 2 promote extracellular regulated Kinase-1/2, c-Jun N-Terminus Kinase and p38 Mitogen-activated protein Kinase activation in breast cancer cells, fibroblasts and embryonic kidney cells?